These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32755460)
1. Web Application for the Automated Extraction of Diagnosis and Site From Pathology Reports for Keratinocyte Cancers. Thompson BS; Hardy S; Pandeya N; Dusingize JC; Green AC; Millane A; Bourke D; Grande R; Bean CD; Olsen CM; Whiteman DC JCO Clin Cancer Inform; 2020 Aug; 4():711-723. PubMed ID: 32755460 [TBL] [Abstract][Full Text] [Related]
2. Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer). Chan AW; Fung K; Tran JM; Kitchen J; Austin PC; Weinstock MA; Rochon PA JAMA Dermatol; 2016 Oct; 152(10):1122-1127. PubMed ID: 27533718 [TBL] [Abstract][Full Text] [Related]
3. The incidence and multiplicity rates of keratinocyte cancers in Australia. Pandeya N; Olsen CM; Whiteman DC Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905 [TBL] [Abstract][Full Text] [Related]
4. A Model to Predict the Risk of Keratinocyte Carcinomas. Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM; J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057 [TBL] [Abstract][Full Text] [Related]
5. Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011. Olsen CM; Williams PF; Whiteman DC J Am Acad Dermatol; 2014 Jul; 71(1):21-6.e1. PubMed ID: 24685358 [TBL] [Abstract][Full Text] [Related]
6. Forearm hair density and risk of keratinocyte cancers in Australian adults. von Schuckmann LA; Hughes MC; Green AC; van der Pols JC Arch Dermatol Res; 2016 Nov; 308(9):617-624. PubMed ID: 27590883 [TBL] [Abstract][Full Text] [Related]
7. Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989. Hollestein LM; de Vries E; Aarts MJ; Schroten C; Nijsten TE J Am Acad Dermatol; 2014 Nov; 71(5):896-903. PubMed ID: 25190484 [TBL] [Abstract][Full Text] [Related]
8. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA; J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281 [TBL] [Abstract][Full Text] [Related]
9. Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma. Dusingize JC; Olsen CM; Pandeya NP; Subramaniam P; Thompson BS; Neale RE; Green AC; Whiteman DC; J Invest Dermatol; 2017 Aug; 137(8):1700-1708. PubMed ID: 28414022 [TBL] [Abstract][Full Text] [Related]
10. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of skin cancer in the general population: clinical accuracy in the Nambour survey. Green A; Leslie D; Weedon D Med J Aust; 1988 May; 148(9):447-50. PubMed ID: 3283506 [TBL] [Abstract][Full Text] [Related]
12. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study. Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of skin cancer in the mature patient. Lai V; Cranwell W; Sinclair R Clin Dermatol; 2018; 36(2):167-176. PubMed ID: 29566921 [TBL] [Abstract][Full Text] [Related]
14. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study. Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384 [TBL] [Abstract][Full Text] [Related]
15. A prospective study of measured body size and height and risk of keratinocyte cancers and melanoma. Lahmann PH; Hughes MC; Williams GM; Green AC Cancer Epidemiol; 2016 Feb; 40():119-25. PubMed ID: 26707237 [TBL] [Abstract][Full Text] [Related]
16. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012. Rogers HW; Weinstock MA; Feldman SR; Coldiron BM JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial. Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD; JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592 [TBL] [Abstract][Full Text] [Related]
19. Patterns of treated non-melanoma skin cancer in Queensland--the region with the highest incidence rates in the world. Stenbeck KD; Balanda KP; Williams MJ; Ring IT; MacLennan R; Chick JE; Morton AP Med J Aust; 1990 Nov; 153(9):511-5. PubMed ID: 2233471 [TBL] [Abstract][Full Text] [Related]
20. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia. Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC; Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]